Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2011

May 27, 2011

34117_dirs_2011-05-27_5cabc70e-ed70-4e53-b0da-4d6ecf7e4803.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2011-05-25

Reporting Person: LAROUNIS GEORGE P (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-05-25 Common Stock M 60000 $0.20 Acquired 380000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-05-25 Employee Stock Option $0.20 M 60000 Disposed 2015-10-25 Common Stock (60000) Direct

Footnotes

F1: Right-To-Buy, pursuant to the Copytele, Inc. 2010 Share Incentive Plan.

F2: Option was amended to change the date that the option is first exerciasable from October 26, 2011 to May 25, 2011